These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


948 related items for PubMed ID: 19251712

  • 1. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM, Loftus EV, Sandborn WJ, Bryant SC, Smyrk TC.
    Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
    [Abstract] [Full Text] [Related]

  • 2. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM, Loftus EV, Sandborn WJ, Bryant SC, Smyrk TC.
    Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714
    [Abstract] [Full Text] [Related]

  • 3. Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM, Loftus EV, Bryant SC, Sandborn WJ, Smyrk TC.
    Am J Gastroenterol; 2008 Feb; 103(2):407-15. PubMed ID: 18289203
    [Abstract] [Full Text] [Related]

  • 4. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L, Mester G, Erdélyi Z, David G, Pandúr T, Balogh M, Fischer S, Vargha P, Lakatos PL.
    Orv Hetil; 2006 Jan 29; 147(4):175-81. PubMed ID: 16515026
    [Abstract] [Full Text] [Related]

  • 5. Polymorphism of HLA-DRB1 gene shows no strong association with ulcerative colitis in Chinese patients.
    Lü M, Xia B.
    Int J Immunogenet; 2006 Feb 29; 33(1):37-40. PubMed ID: 16426241
    [Abstract] [Full Text] [Related]

  • 6. Distinct relationship between HLA-DR genes and intractability of ulcerative colitis.
    Masuda H, Nakamura Y, Tanaka T, Hayakawa S.
    Am J Gastroenterol; 1994 Nov 29; 89(11):1957-62. PubMed ID: 7942717
    [Abstract] [Full Text] [Related]

  • 7. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A, Toyota M, Ikeda H, Morimoto Y, Akino K, Mita H, Suzuki H, Sasaki Y, Kanaseki T, Takamura Y, Soejima H, Urano T, Yanagihara K, Endo T, Hinoda Y, Fujita M, Hosokawa M, Sato N, Tokino T, Imai K.
    Oncogene; 2004 Nov 25; 23(55):8876-86. PubMed ID: 15467734
    [Abstract] [Full Text] [Related]

  • 8. HLA-DRB1*1502 confers susceptibility to ulcerative colitis, but is negatively associated with its intractability: a Korean study.
    Myung SJ, Yang SK, Jung HY, Chang HS, Park B, Hong WS, Kim JH, Min I.
    Int J Colorectal Dis; 2002 Jul 25; 17(4):233-7. PubMed ID: 12073071
    [Abstract] [Full Text] [Related]

  • 9. Different HLA-DR-DQ and MHC class I chain-related gene A (MICA) genotypes in autoimmune and nonautoimmune gestational diabetes in a Swedish population.
    Törn C, Gupta M, Sanjeevi CB, Aberg A, Frid A, Landin-Olsson M.
    Hum Immunol; 2004 Dec 25; 65(12):1443-50. PubMed ID: 15603871
    [Abstract] [Full Text] [Related]

  • 10. Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis.
    Cholongitas E, Papatheodoridis GV, Zappoli P, Giannakopoulos A, Patch D, Marelli L, Shusang V, Kalambokis G, Shirling G, Rolando N, Burroughs AK.
    Liver Transpl; 2007 Apr 25; 13(4):552-7. PubMed ID: 17394153
    [Abstract] [Full Text] [Related]

  • 11. HLA-B is the best candidate of susceptibility genes in HLA for Japanese ulcerative colitis.
    Aizawa H, Kinouchi Y, Negoro K, Nomura E, Imai G, Takahashi S, Takagi S, Kakuta Y, Tosa M, Mochida A, Matsumura Y, Endo K, Shimosegawa T.
    Tissue Antigens; 2009 Jun 25; 73(6):569-74. PubMed ID: 19493234
    [Abstract] [Full Text] [Related]

  • 12. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
    Rubin DT, LoSavio A, Yadron N, Huo D, Hanauer SB.
    Clin Gastroenterol Hepatol; 2006 Nov 25; 4(11):1346-50. PubMed ID: 17059900
    [Abstract] [Full Text] [Related]

  • 13. Evidence of a strong, positive association between atopy and the HLA class II alleles DR4 and DR7.
    Aron Y, Desmazes-Dufeu N, Matran R, Polla BS, Dusser D, Lockhart A, Swierczewski E.
    Clin Exp Allergy; 1996 Jul 25; 26(7):821-8. PubMed ID: 8842557
    [Abstract] [Full Text] [Related]

  • 14. HLA-DRB1 alleles influence clinical phenotypes in Japanese patients with ulcerative colitis.
    Matsumura Y, Kinouchi Y, Nomura E, Negoro K, Kakuta Y, Endo K, Aizawa H, Takagi S, Takahashi S, Shimosegawa T.
    Tissue Antigens; 2008 May 25; 71(5):447-52. PubMed ID: 18416774
    [Abstract] [Full Text] [Related]

  • 15. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis.
    Shetty K, Rybicki L, Brzezinski A, Carey WD, Lashner BA.
    Am J Gastroenterol; 1999 Jun 25; 94(6):1643-9. PubMed ID: 10364038
    [Abstract] [Full Text] [Related]

  • 16. HLA class II DR and DQ genotypes and haplotypes associated with rheumatic fever among a clinically homogeneous patient population of Latvian children.
    Stanevicha V, Eglite J, Zavadska D, Sochnevs A, Shantere R, Gardovska D.
    Arthritis Res Ther; 2007 Jun 25; 9(3):R58. PubMed ID: 17559688
    [Abstract] [Full Text] [Related]

  • 17. Lack of association between HLA-DRB1 alleles of the major histocompatibility complex and p-ANCA status or clinical characteristics in patients with ulcerative colitis.
    Folwaczny C, Zahn R, Brünnler G, Albert E, Koenig A, Noehl N, Loeschke K, Fricke H.
    Z Gastroenterol; 1999 Feb 25; 37(2):133-40. PubMed ID: 10190246
    [Abstract] [Full Text] [Related]

  • 18. Polymorphism in MHC class II transactivator gene is not associated with susceptibility to colorectal cancer in Swedish patients.
    Mumtaz M, Löfgren S, Hugander A, Dimberg J.
    Anticancer Res; 2008 Feb 25; 28(3B):1789-91. PubMed ID: 18630461
    [Abstract] [Full Text] [Related]

  • 19. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
    Lindberg J, Stenling R, Palmqvist R, Rutegård J.
    J Pediatr Gastroenterol Nutr; 2008 May 25; 46(5):534-8. PubMed ID: 18493208
    [Abstract] [Full Text] [Related]

  • 20. Strong protective effect of DR3 against ulcerative colitis in the Spanish population.
    Gómez-García M, Oliver J, Márquez A, Mendoza JL, López-Nevot MA, Fernández-Arquero M, González-Escribano MF, Díaz-Rubio M, de la Concha EG, Urcelay E, Martín J, Martínez A.
    Am J Gastroenterol; 2007 Dec 25; 102(12):2762-6. PubMed ID: 17714554
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 48.